Cannabinoid receptor-2 expression in canine multicentric diffuse large B-cell lymphoma: An immunohistochemical, digital pathology and clinical analysis

Valentina Rinaldi*, Lorenzo Ressel, Laura Bongiovanni, Paolo Emidio Crisi, Andrea Boari, David Killick, Roberto Chiocchetti, Riccardo Finotello

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The cannabinoid 2 receptor (CB2R) is a crucial element of the endocannabinoid system (ECS), which is predominantly expressed on cells of the reticuloendothelial system. Alterations in CB2R expression have shown a prognostic role in various human neoplastic diseases and its expression has been studied in canine mast cell tumours (MCT). Canine diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in dogs and has a variable clinical behaviour. Expression of CB2R was assessed by means of immunohistochemistry in fifteen dogs with proven histological diagnosis of DLBCL. A semiquantitative and quantitative assessment of immunoreactivity (IR) by digital analysis was performed in all cases. Our results indicate that CB2R expression is conserved in canine DLBCL but does not correlate with clinical outcome.

Original languageEnglish
Article number105411
Number of pages6
JournalResearch in Veterinary Science
Volume180
Early online date13 Sept 2024
DOIs
Publication statusPublished - Nov 2024

Bibliographical note

Publisher Copyright:
© 2024 Elsevier Ltd

Keywords

  • CB2R
  • Digital pathology
  • Dog
  • Histopathology
  • Lymphoma

Fingerprint

Dive into the research topics of 'Cannabinoid receptor-2 expression in canine multicentric diffuse large B-cell lymphoma: An immunohistochemical, digital pathology and clinical analysis'. Together they form a unique fingerprint.

Cite this